Kaizaki-Mitsumoto, A; Noguchi, N; Yamaguchi, S; Odanaka, Y; Matsubayashi, S; Kumamoto, H; Fukuhara, K; Funada, M; Wada, K; Numazawa, S. Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market Forensic Toxicol., 1 Jan 2016, 34 (1), 108–114. 854 kB. https://doi.org/10.1007/s11419-015-0293-6 #11 MS,NMR
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #20 Japanese, English abstract MS,NMR,IR,UV
4′-Methyl-α-(pyrrolidin-1-yl)hexanophenone · MPHP
4′-Methyl-3-(pyrrolidin-1-ylmethyl)valerophenone · O-2477
4-Me-α-PiHP · 4′-Methyl-α-(pyrrolidin-1-yl)isohexanophenone · O-2494
PV8 · α-(Pyrrolidin-1-yl)heptanophenone · α-PEP · α-PHPP
2,5-Dimethyl-α-PVP · 2′,5′-Dimethyl-α-(pyrrolidin-1-yl)valerophenone
4-Ethyl-α-PVP · 4′-Ethyl-α-(pyrrolidin-1-yl)valerophenone
2-Me-PiHP · 2-Me-α-PiHP · 2′-Methyl-α-(pyrrolidin-1-yl)isohexanophenone
2-Me-α-PHP · 2′-Methyl-α-(pyrrolidin-1-yl)hexanophenone